387 related articles for article (PubMed ID: 31152821)
1. Clinical validity of saliva and novel technology for cancer detection.
Kaczor-Urbanowicz KE; Wei F; Rao SL; Kim J; Shin H; Cheng J; Tu M; Wong DTW; Kim Y
Biochim Biophys Acta Rev Cancer; 2019 Aug; 1872(1):49-59. PubMed ID: 31152821
[TBL] [Abstract][Full Text] [Related]
2. Electric Field-Induced Release and Measurement (EFIRM): Characterization and Technical Validation of a Novel Liquid Biopsy Platform in Plasma and Saliva.
Tu M; Cheng J; Chen YL; Jea WC; Chen WL; Chen CJ; Ho CL; Huang WL; Lin CC; Su WC; Ye Q; Deignan J; Grody W; Li F; Chia D; Wei F; Liao W; Wong DTW; Strom CM
J Mol Diagn; 2020 Aug; 22(8):1050-1062. PubMed ID: 32497715
[TBL] [Abstract][Full Text] [Related]
3. When Tissue Is the Issue: Expanding Cell-Free DNA "Liquid Biopsies" to Supernatants and Nonplasma Biofluids.
Paulson V; Konnick EQ; Lockwood CH
Clin Lab Med; 2022 Sep; 42(3):485-496. PubMed ID: 36150825
[TBL] [Abstract][Full Text] [Related]
4. Saliva diagnostics - Current views and directions.
Kaczor-Urbanowicz KE; Martin Carreras-Presas C; Aro K; Tu M; Garcia-Godoy F; Wong DT
Exp Biol Med (Maywood); 2017 Mar; 242(5):459-472. PubMed ID: 27903834
[TBL] [Abstract][Full Text] [Related]
5. Saliva Diagnostics.
Nonaka T; Wong DTW
Annu Rev Anal Chem (Palo Alto Calif); 2022 Jun; 15(1):107-121. PubMed ID: 35696523
[TBL] [Abstract][Full Text] [Related]
6. Detection of incipient tumours by screening of circulating plasma DNA: hype or hope?
Lenaerts L; Tuveri S; Jatsenko T; Amant F; Vermeesch JR
Acta Clin Belg; 2020 Feb; 75(1):9-18. PubMed ID: 31578135
[No Abstract] [Full Text] [Related]
7. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor DNA: a promising biomarker in the liquid biopsy of cancer.
Cheng F; Su L; Qian C
Oncotarget; 2016 Jul; 7(30):48832-48841. PubMed ID: 27223063
[TBL] [Abstract][Full Text] [Related]
9. Circulating tumor DNA in early-stage breast cancer: new directions and potential clinical applications.
Croessmann S; Park BH
Clin Adv Hematol Oncol; 2021 Mar; 19(3):155-161. PubMed ID: 33739964
[TBL] [Abstract][Full Text] [Related]
10. Cell-Free DNA in the Liquid Biopsy Context: Role and Differences Between ctDNA and CTC Marker in Cancer Management.
Fici P
Methods Mol Biol; 2019; 1909():47-73. PubMed ID: 30580422
[TBL] [Abstract][Full Text] [Related]
11. Role of Salivary Biomarkers in Oral Cancer Detection.
Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
[TBL] [Abstract][Full Text] [Related]
12. Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management.
Salfer B; Li F; Wong DTW; Zhang L
Clin Chem; 2022 Dec; 68(12):1493-1501. PubMed ID: 36213956
[TBL] [Abstract][Full Text] [Related]
13. Urine-Based Liquid Biopsy for Nonurological Cancers.
Jain S; Lin SY; Song W; Su YH
Genet Test Mol Biomarkers; 2019 Apr; 23(4):277-283. PubMed ID: 30986103
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy in Head and Neck Cancer: Promises and Challenges.
Nonaka T; Wong DTW
J Dent Res; 2018 Jun; 97(6):701-708. PubMed ID: 29513618
[TBL] [Abstract][Full Text] [Related]
15. Nanotechnology Strategies for the Analysis of Circulating Tumor DNA: A Review.
Chen X; Wang L; Lou J
Med Sci Monit; 2020 Mar; 26():e921040. PubMed ID: 32200389
[TBL] [Abstract][Full Text] [Related]
16. ctDNA as a cancer biomarker: A broad overview.
Pessoa LS; Heringer M; Ferrer VP
Crit Rev Oncol Hematol; 2020 Nov; 155():103109. PubMed ID: 33049662
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free tumor DNA analysis in pediatric cancers.
Andersson D; Fagman H; Dalin MG; Ståhlberg A
Mol Aspects Med; 2020 Apr; 72():100819. PubMed ID: 31563277
[TBL] [Abstract][Full Text] [Related]
18. Clinical implementation and current advancement of blood liquid biopsy in cancer.
Watanabe K; Nakamura Y; Low SK
J Hum Genet; 2021 Sep; 66(9):909-926. PubMed ID: 34088974
[TBL] [Abstract][Full Text] [Related]
19. Liquid Biopsy in Solid Malignancy.
Scarlotta M; Simsek C; Kim AK
Genet Test Mol Biomarkers; 2019 Apr; 23(4):284-296. PubMed ID: 30916594
[TBL] [Abstract][Full Text] [Related]
20. Blood and saliva-derived ctDNA is a marker of residual disease after treatment and correlates with recurrence in human papillomavirus-associated head and neck cancer.
Ferrier ST; Tsering T; Sadeghi N; Zeitouni A; Burnier JV
Cancer Med; 2023 Aug; 12(15):15777-15787. PubMed ID: 37526056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
